Literature DB >> 7001615

Guillain-Barré syndrome after vaccination with human diploid cell rabies vaccine.

E Bøe, H Nyland.   

Abstract

A 14-year-old boy developed an acute Guillain-Barré syndrome (GBS) 14 days after receiving the second prophylactic dose of human diploid cell rabies vaccine. The symmetrical sensorimotor polyneuropathy included bilateral facial weakness. GBS after vaccination with human diploid cell rabies vaccine must be extremely rare, and has not hitherto been reported.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001615     DOI: 10.3109/inf.1980.12.issue-3.12

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

Review 1.  Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

2.  Dog bites in Bosnia.

Authors:  A Croft; R Archer
Journal:  Br J Gen Pract       Date:  1997-07       Impact factor: 5.386

3.  In pursuit of the perfect rabies vaccine.

Authors:  S D Gardner
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

4.  A decision-analytic approach to postexposure rabies prophylaxis.

Authors:  S B Cantor; R D Clover; R F Thompson
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

5.  Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization.

Authors:  G S Turner; K G Nicholson; D A Tyrrell; F Y Aoki
Journal:  J Hyg (Lond)       Date:  1982-08

6.  Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost.

Authors:  D L Noah; M G Smith; J C Gotthardt; J W Krebs; D Green; J E Childs
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

7.  Vocal Fold Paralysis Following COVID-19 Vaccination: Query of VAERS Database.

Authors:  Osama A Hamdi; Rachel H Jonas; James J Daniero
Journal:  J Voice       Date:  2022-01-24       Impact factor: 2.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.